Clinical practice recommendations for Bangpungtongseong-san (Bofutsusho-san) and Bangkihwangki-tang(Boiogito) in obesity (비만치료 및 체중 감량에서 방풍통성산과 방기황기탕 사용에 대한 임상 권고안)

박정현; Hojun Kim (김호준)

Clinical practice recommendations for Bangpungtongseong-san (Bofutsusho-san) and Bangkihwangki-tang(Boiogito) in obesity

Journal of Korean Medicine for Obesity Research
Abbr : J Korean Med Obes Res
2012, 12(1), pp.48-58
Publisher : The Society of Korean Medicine for Obesity Research
Research Area : Medicine and Pharmacy > Korean Medicine

¹강남경희한방병원 체형관리센터
²동국대학교 한의과대학 한방재활의학과

ABSTRACT

ObjectivesThese prescribing recommendations have been written to guide clinicians on the appropriate use of Bangpungtongseong-san(BT) andBangkihwangki-tang(BH) in the treatment of obesity. These recommendation are aimed at providing evidence based information concerning diagnosis and management of obesity. MethodsWe collected all relevant references about treatment effect of BT and BH on obesity in the forms of meta-analysis, systematic review,randomized controlled trial, case-control study, observational study and practice guideline from international and domestic databases and paperjournals. We examined treatment effect, side effects, recommendations for dose, indication and contraindication of BT and BH. ResultsThe treatment effect of BT and BH on obesity has been proved through clinical trial. BT is indicated for obese patients (Body mass index,BMI≥25) with strong abdomen and a tendency to constipation, BH is indicated for obese patients (BMI≥25) with a fair skinned, soft muscled,edematous and sweat easily. ConclusionWe wish the information contained in theses recommendations will help clinicians reach a reasonable and beneficial decision withevidence-based results. Further studies are strongly needed to develop better treatment strategies for herbal medicines on obesity.

KEYWORDS

clinical practice recommendation, Bangpungtongseong-san(Bofutsusho-san), Bangkihwangki-tang(Boiogito), herbal medicines, obesity

Citation status

* References for papers published after 2023 are currently being built.

[journal] Hasani-Ranjbar S / 2009 / A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity / World Journal of Gastroenterology 15(25) : 3073~3085

[journal] 강경원 / 2009 / The Comparison of Pattern Identification Diagnosis According to Symptom Scale Based on Obesity Pattern Identification Questionnaire / 한방비만학회지 / 한방비만학회 9(1) : 37~44

[journal] 안형식 / 2007 / 임상진료지침의 개념과 활성화 방안 / 대한소화기학회지 49(4) : 105~118

[journal] 김호준 / 2007 / 비만치료 및 체중감량에서의 적절한 마황사용에 대한임상 진료지침 개발 / 대한한방비만학회지 7(2) : 27~37

[journal] 박정현 / 2011 / Review on the Research Related to Bangpungtongseong-san(Bofutsusho-san ) in Korea / 한방재활의학과학회지 / 한방재활의학과학회 21(2) : 189~202

[journal] Takahama M. / 1995 / Efficacy of Boi-ogi-to in the treatment of rheumatoid arthritis / Nihon Toyo Igaku Zasshi 45(3) : 569~574

[journal] Noguchi J / 2004 / Efficacy of Boi-ogito for ethical use for osteoarthritis of the knee with joint fluid / Seikei Saigai Geka 47 : 999~1005

[journal] Shimada T / 2009 / Preventive effect of Boiogito on metabolic disorders in the TSOD Mouse, a model of spontaneous obese Type II diabetes mellitus / Evid Based Complement Alternat Med : 1~8

[book] Harbour RT / 2008 / SIGN 50: a guideline developer's handbook / Scottish Intercollegiate Guidelines : 57~

[book] Sackett DL. / 2000 / Evidence-based Medicine: How to Practice and Teach EBM / Churchill Livingstone

[book] 허준 / 1983 / 동의보감 / 남산당 : 207~239

[web] / Kampo Co / http://www.tsumura.co.jp/english/.../pi/JPR_T062.pdf

[book] 劉河間 / 1988 / 宣明論方. 券十 문연각서고전서 중의학대계 / 여강출판사 : 768~

[book] 張仲景 / 1985 / 金櫃要略方論 / 성보사 : 21~

[web] / 식약청 / http://ezdrug.kfda.go.kr

[journal] 최은미 / 2001 / 비만 환자에 대한 방풍통성산의 치료효과 / 대한한방비만학회지 1(1) : 1~11

[journal] 배정환 / 2002 / 비만 환자에 있어 양해(방풍통성산)의 유용성 평가를 위한 임상시험 / 한방재활의학과학회지 13(1) : 37~46

[journal] 신대희 / 2008 / Clinical study of Bangpoongtongsungsan on body weight change in subjects with obesity / 대한한의학 방제학회지 / 대한한의학방제학회 16(2) : 133~144

[journal] 이지은 / 2010 / Randomized, Double Blind, Placebo-Controlled Study of Bofu-tsusho-san on Obese Patients / 한방비만학회지 / 한방비만학회 10(1) : 1~16

[journal] 박정현 / 2011 / Efficacy and Adverse Events of Bangpungtongseong-san (Bofutsusho-san ) and Bangkihwangki-tang(Boiogiot-tang ) by Oriental Obesity Pattern Identification on Obese Subjects: Randomized, Double Blind, Placebo-controlled Trial / 한방재활의학과학회지 / 한방재활의학과학회 21(2) : 265~278

[journal] Itoh T / 2005 / The Effect of Bofutsushosan on weight reduction in human / Japanese Journal of Oriental Medicine 56(6) : 933~939

[journal] Akiyama T / 1998 / Efficacy of Bofutsushosan for a patient worrying about obesity with gene mutation β-adrenergic receptors / Digestion and Absorption 21(2) : 159~162

[journal] Hioki C / 2004 / Efficacy of Bofutsusho-san, an oriental herbal medicine, in obese Japanese women with impaired glucose tolerance / Clinical Experimental Pharmacological Physiology 31(9) : 614~619

[journal] Hioki C / 2008 / Traditional medicine Bofutsusho-san, improves hyperinsulinemia in obese subjects / Journal of Chinese Medicine 3(6) : 312~316

[journal] 吉田麻美 / 1998 / 防己黃芪湯對肥滿型糖尿病的效果 / 日本東洋醫學雜誌 49 : 249~256

[journal] 문진석 / 2007 / 한의사와 환자의 설문을 통한 비만 변증지표 연구 / 대한한방비만학회지 7(1) : 55~69

[journal] 박정현 / 2011 / 방풍통성산과 방기황기탕의 비만 변증및 유전자다형성에 따른 치료 효과 / 동국대학교논문집

[journal] 이기훈 / 2009 / Three Cases Report of Children Psoriasis treated by Bangpungtongsungsan / 대한한방소아과학회지 / 대한한방소아과학회 23(3) : 207~216

[book] 윤길영 / 1992 / 동의임상방제학 / 명보출판사 : 52~54

[book] 이종대 / 2004 / 빈용 101 처방 / 정담출판사 : 978~

[book] WHO Western Pacific Region / 2002 / The Asia-Pacific perspective:Redefining obesity and its treatment : 15~21

[journal] Plodkowski RA / 2003 / Medical nutrition therapy for the treatment of obesity / Endocrinol Metab Clin North Am 32 : 935~969

[journal] Hensrud DD. / 2000 / Pharmacotherapy for obesity / Med Clin North Am 84 : 463~476

[journal] 유순집 / 2008 / Pharmacological Treatment of Obesity / Endocrinology and Metabolism / 대한내분비학회 23(4) : 223~233

KJCKorea
Journal Central

Journal of Korean Medicine for Obesity Research 2023 KCI Impact Factor : 0.43